Colorado BioScience Association Debuts Quarterly Newsletter: The CBSA FOCUS
Colorado BioScience Association (CBSA) has published the first issue of its quarterly newsletter, “The CBSA FOCUS.” Featured articles in the Spring 2005 issue cover the Colorado Technology Survey; McKinley Medical company’s new pain management product targeting the plastic surgery industry; and Dr. Michael Bristow, noted professor, physician and founder of both the Myogen and ARCA Discovery biotech companies.
Denver, CO, May 31, 2005 --(PR.com)-- The first issue of “The CBSA FOCUS,” the Colorado BioScience Association’s quarterly newsletter has rolled off the presses. The announcement is made by Denise Brown, CBSA executive director, who says the new quarterly publication joins the association’s annual magazine, “Bioscience Colorado,” to help further share the many success stories and highlights of Colorado’s medical device and biotechnology industries.
Featured articles in the debut FOCUS issue cover the Colorado Technology Survey; McKinley Medical company’s new pain management product targeting the plastic surgery industry; and Dr. Michael Bristow, noted professor, physician and founder of both the Myogen and ARCA Discovery biotech companies. Other topics covered include upcoming CBSA events, executive report, regulatory update on new FDA rules, and news briefs. Here’s a sampling of the feature articles and links to the articles and PDF of the newsletter:
“Bioscience Execs Upbeat: Survey Shows Increase In New Product Development” -- A recent survey focused on technology in Colorado shows bioscience companies plan to invest more money and human capital in research and development during the first six months of 2005. You can read the FOCUS article about the survey at http://www.pr.com/upload/presskit_1811_1121365070.pdf.
“McKinley Medical Carves Out a New Niche in Pain Management” -- Aesthetic surgery is booming in America, thanks to extensive media coverage that gives the public an eye-opening view of what plastic surgeons can do. As the population ages, people seem determined to stay youthful and lean as long as possible, and many of them are opting for appearance-enhancing procedures. A Colorado medical device company is taking advantage of this trend. McKinley Medical, LLC, based in Wheat Ridge, with a facility in Blackpool, Lancashire, England, provides infusion therapy for post-operative pain management. A leader in pain management systems for general and orthopedic surgery, McKinley currently targets three popular aesthetic/reconstructive procedures: abdominoplasty, breast augmentation and breast reconstruction. Read the FOCUS article about McKinley at http://www.pr.com/upload/presskit_1811_1121366349.pdf.
“Colorado’s Triple Threat: Dr. Michael R. Bristow - Clinician, Researcher and Entrepreneur” – Dr. Michael R. Bristow is a professor of cardiology at the University of Colorado Health Sciences Center, co-director of the University of Colorado Cardiovascular Institute, and founder of Myogen, one of Colorado’s best bioscience success stories. “Everything I do,” he says, “is designed to develop new approaches for the treatment of heart failure.” You can read the FOCUS article about Dr. Bristow at http://www.pr.com/upload/presskit_1811_1121365733.pdf.
A pdf of the full first issue of FOCUS is found at this link:
http://www.pr.com/upload/presskit_1811_1122316006.pdf.
The CBSA FOCUS newsletter is edited, written and produced by the Sage Public Relations Group (www.sagepublicrelations.com) in collaboration with Griff/SMC (www.griffsmc.com). Design and production is by New Moon Communications. For editorial comments and content ideas contact Jon Pushkin, Editor, 303-733-3441; jon@pushkinpr.com (www.pushkinpr.com).
Most recently, Ed Wood, CEO of Summit Roundtable (www.summitroundtable.com) in Lakewood, was named Chairperson of the Board of Directors for CBSA. Vice Chairperson of the CBSA board is Jack Wheeler, CEO of Microphage, Inc. (www.micro-phage.com), headquartered in Longmont. In addition, four new board members were added to the CBSA board: Tom Miller, President, Emerging Medical Technologies; Tom Cycyota, President & CEO, AlloSource (www.allosource.org); Tom Roach, CPA, Ernst & Young (www.ey.com); and Maggie Chamberlin Holben, APR, Absolutely Public Relations (www.absolutelypr.com).
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of 304 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at www.cobioscience.com
###
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association, 303.592.4073, E-mail: dbrown@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, 303.984.9801 or 303.669.3558, E-mail: maggie@absolutelypr.com
Featured articles in the debut FOCUS issue cover the Colorado Technology Survey; McKinley Medical company’s new pain management product targeting the plastic surgery industry; and Dr. Michael Bristow, noted professor, physician and founder of both the Myogen and ARCA Discovery biotech companies. Other topics covered include upcoming CBSA events, executive report, regulatory update on new FDA rules, and news briefs. Here’s a sampling of the feature articles and links to the articles and PDF of the newsletter:
“Bioscience Execs Upbeat: Survey Shows Increase In New Product Development” -- A recent survey focused on technology in Colorado shows bioscience companies plan to invest more money and human capital in research and development during the first six months of 2005. You can read the FOCUS article about the survey at http://www.pr.com/upload/presskit_1811_1121365070.pdf.
“McKinley Medical Carves Out a New Niche in Pain Management” -- Aesthetic surgery is booming in America, thanks to extensive media coverage that gives the public an eye-opening view of what plastic surgeons can do. As the population ages, people seem determined to stay youthful and lean as long as possible, and many of them are opting for appearance-enhancing procedures. A Colorado medical device company is taking advantage of this trend. McKinley Medical, LLC, based in Wheat Ridge, with a facility in Blackpool, Lancashire, England, provides infusion therapy for post-operative pain management. A leader in pain management systems for general and orthopedic surgery, McKinley currently targets three popular aesthetic/reconstructive procedures: abdominoplasty, breast augmentation and breast reconstruction. Read the FOCUS article about McKinley at http://www.pr.com/upload/presskit_1811_1121366349.pdf.
“Colorado’s Triple Threat: Dr. Michael R. Bristow - Clinician, Researcher and Entrepreneur” – Dr. Michael R. Bristow is a professor of cardiology at the University of Colorado Health Sciences Center, co-director of the University of Colorado Cardiovascular Institute, and founder of Myogen, one of Colorado’s best bioscience success stories. “Everything I do,” he says, “is designed to develop new approaches for the treatment of heart failure.” You can read the FOCUS article about Dr. Bristow at http://www.pr.com/upload/presskit_1811_1121365733.pdf.
A pdf of the full first issue of FOCUS is found at this link:
http://www.pr.com/upload/presskit_1811_1122316006.pdf.
The CBSA FOCUS newsletter is edited, written and produced by the Sage Public Relations Group (www.sagepublicrelations.com) in collaboration with Griff/SMC (www.griffsmc.com). Design and production is by New Moon Communications. For editorial comments and content ideas contact Jon Pushkin, Editor, 303-733-3441; jon@pushkinpr.com (www.pushkinpr.com).
Most recently, Ed Wood, CEO of Summit Roundtable (www.summitroundtable.com) in Lakewood, was named Chairperson of the Board of Directors for CBSA. Vice Chairperson of the CBSA board is Jack Wheeler, CEO of Microphage, Inc. (www.micro-phage.com), headquartered in Longmont. In addition, four new board members were added to the CBSA board: Tom Miller, President, Emerging Medical Technologies; Tom Cycyota, President & CEO, AlloSource (www.allosource.org); Tom Roach, CPA, Ernst & Young (www.ey.com); and Maggie Chamberlin Holben, APR, Absolutely Public Relations (www.absolutelypr.com).
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of 304 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at www.cobioscience.com
###
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association, 303.592.4073, E-mail: dbrown@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, 303.984.9801 or 303.669.3558, E-mail: maggie@absolutelypr.com
Contact
Colorado Bioscience Association
Denise Brown
303.592.4073
http://www.cobioscience.com
Maggie Chamberlin Holben, APR
Absolutely Public Relations
303.984.9801 or 303.669.3558
E-mail: maggie@absolutelypr.com
Denise Brown
303.592.4073
http://www.cobioscience.com
Maggie Chamberlin Holben, APR
Absolutely Public Relations
303.984.9801 or 303.669.3558
E-mail: maggie@absolutelypr.com
Contact
Categories